Local Institution
Malvern, Victoria 3144
0 studies enrolling now · 13 studies all time
What they study most
Advanced Cutaneous Melanoma, Arthritis, Rheumatoid, Cancer of the Stomach, Deep Vein Thrombosis, Gastric Cancer, Gastroesophageal Junction, High Risk Stage III Melanoma, Lymphoma, Multiple Myeloma, Pulmonary Embolism, Renal Cell Carcinoma, Rheumatoid Arthritis
Studies at this site
- An Investigational Immuno-Therapy Safety and Efficacy Study of Multiple Administration Regimens for Nivolumab Plus Ipilimumab in Subjects With Renal Cell Carcinoma — Completed
- Phase III Study of Lenalidomide and Dexamethasone With or Without Elotuzumab to Treat Relapsed or Refractory Multiple Myeloma — Completed
- A Multi-National, Prospective, Observational Study in Patients With Unresectable or Metastatic Melanoma — Completed
- An Investigational Immuno-therapy Study of Relatlimab Plus Nivolumab Compared to Various Standard-of-Care Therapies in Previously Treated Participants With Recurrent, Advanced or Metastatic Gastric Cancer or Gastroesophageal Junction Adenocarcinoma — Withdrawn before enrolling
- Efficacy Study of Ipilimumab Versus Placebo to Prevent Recurrence After Complete Resection of High Risk Stage III Melanoma — Completed
- Efficacy and Safety Study of Abatacept Subcutaneous Plus Methotrexate in Inducing Remission in Adults With Very Early Rheumatoid Arthritis — Completed
- Study of Abatacept Versus Placebo to Assess the Prevention of Rheumatoid Arthritis (RA) in Adult Patients — Completed
- Abatacept and Infliximab in Combination With Methotrexate in Subjects With Rheumatoid Arthritis — Completed
- Phase IIIB Subcutaneous Abatacept Monotherapy Study — Completed
- Abatacept in the Treatment and Prevention of Active Systemic Lupus Erythematosus (SLE) Flares in Combination With Prednisone — Completed
- Study of an Investigational Drug for the Prevention of Thrombosis-related Events Following Hip Replacement Surgery (ADVANCE-3) — Completed
- Abatacept With Methotrexate- Phase IIB — Completed
- Remission and Joint Damage Progression in Early Rheumatoid Arthritis — Completed